Globaler Markt für Prostatakrebsdiagnostik – Branchentrends und Prognose bis 2031

Bericht anpassenBericht anpassen Jetzt kaufen Jetzt kaufen Kostenloser Beispielbericht Kostenloser Beispielbericht
Home Medical Devices Global Prostate Cancer Diagnostics Market
Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Globaler Markt für Prostatakrebsdiagnostik – Branchentrends und Prognose bis 2031

  • Medical Devices
  • Upcoming Reports
  • Feb 2024
  • Global
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60
Jetzt kaufen Jetzt kaufen

Global Prostate Cancer Diagnostics Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
 2024 –2031
Diagramm Marktgröße (Basisjahr)
 USD 4,196.09 Million
Diagramm Marktgröße (Prognosejahr)
 USD 9,327.01 Million
Diagramm CAGR
 %
Diagramm Wichtige Marktteilnehmer
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Anfrage zur Freischaltung

>Globaler Markt für Prostatakrebsdiagnostik, nach Produkttyp (Instrumente, Reagenzien und Verbrauchsmaterialien, Zubehör), Diagnostiktyp (vorläufige Screeningtests, Bestätigungstests), Altersgruppe (Erwachsene, Kinder, Geriatrie), Typ (Prostataadenokarzinom, kleinzelliges Karzinom, sonstige), Stadium (lokalisierter Prostatakrebs, rezidivierender/fortgeschrittener Prostatakrebs, kastrationsresistenter Prostatakrebs (metastasiert, nicht metastasiert), Probentyp (Blut, Gewebe, Urin, sonstige), Endbenutzer (unabhängige Diagnoselabore, Krankenhäuser, Krebsforschungsinstitute, Kliniken, ambulante chirurgische Zentren, sonstige), Vertriebskanal (direkte Ausschreibung, Einzelhandelsverkauf) – Branchentrends und Prognose bis 2031.

Markt für Prostatakrebsdiagnostik

Marktanalyse und -größe für Prostatakrebsdiagnostik   

Die Diagnostik von Prostatakrebs spielt eine wichtige Rolle bei der Früherkennung und effizienten Behandlung der Krankheit. Sie umfasst die Verwendung von Instrumenten, Reagenzien und Verbrauchsmaterialien sowie Zubehör. Der PSA-Test ist die häufigste vorläufige Diagnose von Prostatakrebs, für die möglicherweise weitere Bestätigungstests zur Erkennung des Krebses erforderlich sind, möglicherweise jedoch nicht.

Der Einsatz von Prostatakrebsdiagnostik hat mehrere Vorteile, beispielsweise hilft er bei der Früherkennung von Prostatakrebs in lokalisierten Stadien und unterstützt die Menschen so bei der Erzielung eines effizienten Gesundheitsmanagements. Der Einsatz von Prostatakrebsdiagnostik wird weltweit immer beliebter, insbesondere in Schwellenländern mit steigenden Gesundheitsstandards.

Data Bridge Market Research analysiert, dass der globale Markt für Prostatakrebsdiagnostik, der im Jahr 2023 4.196,09 Millionen USD betrug, bis 2031 voraussichtlich 9.327,01 Millionen USD erreichen wird und im Prognosezeitraum eine durchschnittliche jährliche Wachstumsrate von 10,5 % aufweisen wird. Die „Erwachsenen“ haben aufgrund der höheren Krebsprävalenz bei erwachsenen Männern den größten Marktanteil im Altersgruppensegment des Marktes. Neben Einblicken in Marktszenarien wie Marktwert, Wachstumsrate, Segmentierung, geografische Abdeckung und wichtige Akteure enthalten die von Data Bridge Market Research zusammengestellten Marktberichte auch eingehende Expertenanalysen, Patientenepidemiologie, Pipeline-Analysen, Preisanalysen und regulatorische Rahmenbedingungen.

Marktumfang und -segmentierung für Prostatakrebsdiagnostik

Berichtsmetrik

Details

Prognosezeitraum

2024 bis 2031

Basisjahr

2023

Historische Jahre

2022 (anpassbar auf 2016–2021)

Quantitative Einheiten

Umsatz in Mio. USD, Mengen in Einheiten, Preise in USD

Abgedeckte Segmente

Nach Produkttyp (Instrumente, Reagenzien und Verbrauchsmaterialien, Zubehör), Diagnosetyp (Vorabscreeningtests, Bestätigungstests), Altersgruppe (Erwachsene, Kinder, Geriatrie), Typ (Prostata-Adenokarzinom, kleinzelliges Karzinom, Sonstiges), Stadium (lokalisierter Prostatakrebs, rezidivierender/fortgeschrittener Prostatakrebs, kastrationsresistenter Prostatakrebs (metastasierend, nicht metastasierend), Probentyp (Blut, Gewebe, Urin, Sonstiges), Endnutzer (unabhängige Diagnoselabore, Krankenhäuser, Krebsforschungsinstitute, Kliniken, ambulante chirurgische Zentren, Sonstiges), Vertriebskanal (Direktausschreibung, Einzelhandel)

Abgedeckte Länder

USA, Kanada, Mexiko, Deutschland, Frankreich, Großbritannien, Belgien, Litauen, Österreich, Irland, Norwegen, Polen, Italien, Spanien, Russland, Türkei, Niederlande, Schweiz, Restliches Europa, Japan, China, Südkorea, Indien, Australien, Singapur, Thailand, Malaysia, Indonesien, Philippinen, Restlicher asiatisch-pazifischer Raum, Brasilien, Argentinien, Restliches Südamerika, Südafrika, Saudi-Arabien, Vereinigte Arabische Emirate, Ägypten, Israel, Restlicher Naher Osten und Afrika.

Abgedeckte Marktteilnehmer

F. Hoffmann-La Roche Ltd (Schweiz), ACON Laboratories, Inc. (USA), HUMASIS (Südkorea), Teco Diagnostics (USA), Hologic Inc. (USA), Accuquik Test Kits (USA), MDxHealthcare (Belgien), Abbott (USA), Siemens Healthcare GmbH (Deutschland), OPKO Health Inc. (USA), Myriad Genetics, Inc. (USA), DiaSorin SpA (Italien), Beckman Coulter, Inc. (eine Tochtergesellschaft von Danaher) (USA), Genomic Health, Inc. (eine Tochtergesellschaft von Exact Sciences Corporation) (USA), bioMérieux SA (Frankreich), Metamark Genetics, Inc. (USA), Prostatype Genomics (Schweiz), Fujirebio (Belgien), Proteomedix (Schweiz), Eurolyser Diagnostica GmbH (Österreich)

Marktchancen
  • Fortschritte in der Biomarkerforschung
  • Personalisierte Medizin im Fokus

Marktdefinition

Die Diagnose von Prostatakrebs umfasst eine Kombination aus der Erhebung der medizinischen Vorgeschichte, einer körperlichen Untersuchung und spezifischen Diagnosetests. Zu den ersten Schritten gehört oft eine digitale rektale Untersuchung (DRE), um die Prostata auf Anomalien zu untersuchen. Bluttests, wie der Test auf prostataspezifisches Antigen (PSA), messen erhöhte Werte eines Proteins, das mit Prostataerkrankungen wie Krebs in Verbindung gebracht wird. Bildgebende Verfahren wie Ultraschall, Magnetresonanztomographie (MRT) oder Computertomographie (CT) können eingesetzt werden, um die Prostata und das umliegende Gewebe auf Anzeichen von Krebs zu untersuchen. Bei einer Biopsie, die in der Regel durch bildgebende Verfahren gesteuert wird, werden Gewebeproben aus der Prostata entnommen und im Labor analysiert, um das Vorhandensein von Krebszellen zu bestätigen und die Aggressivität des Krebses festzustellen. Die kombinierten Ergebnisse dieser Untersuchungen helfen den Ärzten, eine genaue Diagnose zu stellen und eine geeignete Behandlung für den Patienten festzulegen.

Globale Marktdynamik für Prostatakrebsdiagnostik

Treiber

  • Zunehmende Alterung der Bevölkerung

Der demografische Wandel hin zu einer alternden Bevölkerung ist ein wichtiger Treiber für den Markt für Prostatakrebsdiagnostik. Prostatakrebs betrifft überwiegend ältere Männer, und da der Anteil älterer Menschen weltweit steigt, steigt natürlich auch die Zahl der Menschen mit Prostatakrebsrisiko. Die ältere Bevölkerungsgruppe unterzieht sich häufig routinemäßigen Vorsorgeuntersuchungen und Diagnosetests , was zur allgemeinen Nachfrage nach Prostatakrebsdiagnostik beiträgt.

  • Steigende Inzidenz von Prostatakrebs

Die Zahl der Prostatakrebserkrankungen nimmt stetig zu, was sie zu einem wichtigen Wachstumstreiber für den Diagnosemarkt macht. Faktoren wie Veränderungen des Lebensstils, Umwelteinflüsse und genetische Veranlagungen tragen zur höheren Zahl von Prostatakrebsfällen bei. Das gestiegene Bewusstsein für die Krankheit und die Bedeutung einer Früherkennung haben dazu geführt, dass mehr Menschen nach Diagnoseuntersuchungen suchen, was die Nachfrage nach fortschrittlichen und präzisen Diagnoseinstrumenten auf dem Markt weiter ankurbelt.

Gelegenheiten

  • Fortschritte in der Biomarkerforschung

Die laufende Erforschung neuer Biomarker, die mit Prostatakrebs in Zusammenhang stehen, wie genetische Mutationen, zirkulierende Tumorzellen und bestimmte Proteine, eröffnet Möglichkeiten für die Entwicklung hochempfindlicher und spezifischer Diagnosetests. Da Forscher immer differenziertere Details über die molekularen Signaturen von Prostatakrebs entdecken, können Diagnoseunternehmen dieses Wissen nutzen, um die Präzision und Zuverlässigkeit von Diagnoseinstrumenten zu verbessern und so letztlich die Früherkennungsraten und die Patientenergebnisse zu verbessern.

  • Fokus auf personalisierte Medizin

Die zunehmende Bedeutung der personalisierten Medizin in der Prostatakrebsdiagnostik bietet die Möglichkeit, diagnostische Ansätze auf der Grundlage individueller Patientenmerkmale zuzuschneiden. Die Integration von genetischem Profiling, molekularer Analyse und patientenspezifischen Faktoren ermöglicht eine gezieltere und effektivere Diagnosestrategie. Dieser personalisierte Ansatz verbessert nicht nur die Genauigkeit der Prostatakrebsdiagnose, sondern eröffnet auch Möglichkeiten für die Entwicklung maßgeschneiderter Behandlungspläne, die dem allgemeinen Trend im Gesundheitswesen hin zu einer individuelleren und patientenzentrierteren Versorgung entsprechen.

Einschränkungen/Herausforderungen

  • Begrenzte Spezifität von Biomarkern

Die Herausforderung besteht darin, dass einige Biomarker, die bei der Prostatakrebsdiagnostik verwendet werden, möglicherweise nicht die erforderliche Spezifität aufweisen, um genau zwischen gutartigen und aggressiven Formen der Krankheit zu unterscheiden. Diese Einschränkung kann zu falsch positiven Ergebnissen führen und unnötige invasive Verfahren und Überbehandlungen nach sich ziehen. Die Verbesserung der Spezifität von Biomarkern ist entscheidend, um die Präzision diagnostischer Tests zu erhöhen und eine fundiertere klinische Entscheidungsfindung zu gewährleisten.

  • Invasiver Charakter diagnostischer Verfahren

Invasive Diagnoseverfahren, insbesondere Prostatabiopsien, stellen aufgrund der damit verbundenen Unannehmlichkeiten, möglichen Nebenwirkungen und des Infektionsrisikos eine erhebliche Herausforderung dar. Die Befürchtungen und die Abneigung der Patienten gegenüber diesen Verfahren können dazu führen, dass Diagnoseuntersuchungen verzögert oder vermieden werden, wodurch möglicherweise Gelegenheiten zur Früherkennung von Krebs verpasst werden. Die Entwicklung weniger invasiver oder nicht-invasiver Diagnosealternativen ist von entscheidender Bedeutung, um eine breitere Patientenbeteiligung zu fördern und die allgemeine Patientenerfahrung bei der Prostatakrebsdiagnostik zu verbessern.

Dieser Marktbericht zur Prostatakrebsdiagnostik enthält Einzelheiten zu neuen Entwicklungen, Handelsvorschriften, Import-Export-Analysen, Produktionsanalysen, Wertschöpfungskettenoptimierungen, Marktanteilen, Auswirkungen inländischer und lokaler Marktteilnehmer, analysiert Chancen in Bezug auf neue Einnahmequellen, Änderungen der Marktvorschriften, strategische Marktwachstumsanalysen, Marktgröße, Kategoriemarktwachstum, Anwendungsnischen und -dominanz, Produktzulassungen, Produkteinführungen, geografische Expansionen und technologische Innovationen auf dem Markt. Um weitere Informationen zum Markt für Prostatakrebsdiagnostik zu erhalten, wenden Sie sich an Data Bridge Market Research, um einen Analystenbericht zu erhalten. Unser Team hilft Ihnen dabei, eine fundierte Marktentscheidung zu treffen, um Marktwachstum zu erzielen.

Jüngste Entwicklungen

  • Im Oktober 2020 gab die Siemens Healthcare GmbH bekannt, dass sie den Biograph Vision Quadra Extended Axial FoV PET/CT Scanner auf den Markt gebracht hat. Dieser Scanner ist der branchenweit empfindlichste Scanner mit erweitertem Sichtfeld, der für klinische und Forschungszwecke entwickelt wurde. Das Produkt ist von hohem klinischem Nutzen und wird die Nachfrage nach Krebsdiagnoseverfahren erhöhen und den Umsatz des Unternehmens steigern.
  • Im März 2020 gaben DiaSorin SpA und TTP plc, ein führendes unabhängiges Technologie- und Produktentwicklungsunternehmen, bekannt, dass sie eine exklusive Lizenz- und Technologietransfervereinbarung unterzeichnet haben, im Rahmen derer DiaSorin Zugang zu TTPs Puckdx TM erhält, einer flexiblen und kostengünstigen Plattform für die Automatisierung von diagnostischen Tests von der Probe bis zur Antwort. Dies wird die Weiterentwicklung des diagnostischen Geschäftsprofils des Unternehmens vorantreiben und die zukünftige Geschäftsentwicklung unterstützen.

Globaler Marktumfang für Prostatakrebsdiagnostik

Der Markt für Prostatakrebsdiagnostik ist nach Produkttyp, Diagnostiktyp, Altersgruppe, Typ, Stadium, Probentyp, Endbenutzer und Vertriebskanal segmentiert. Das Wachstum dieser Segmente hilft Ihnen bei der Analyse schwacher Wachstumssegmente in den Branchen und bietet den Benutzern einen wertvollen Marktüberblick und Markteinblicke, die ihnen bei der strategischen Entscheidungsfindung zur Identifizierung der wichtigsten Marktanwendungen helfen.

Produkttyp

  • Instrumente
  • Reagenzien und Verbrauchsmaterialien
  • Zubehör

Diagnosetyp

  • Vorab-Screening-Tests
  • Bestätigungstests

Altersgruppe

  • Erwachsene
  • Pädiatrie
  • Geriatrie

Typ

  • Prostata-Adenokarzinom
  • Kleinzelliges Karzinom
  • Sonstiges

Bühne

  • Lokalisierter Prostatakrebs
  • Wiederkehrender/fortgeschrittener Prostatakrebs
  • Kastrationsresistenter Prostatakrebs (metastasiert und nicht metastasiert )

Probentyp

  • Blut
  • Gewebe
  • Urin
  • Sonstiges

Endbenutzer

  • Unabhängige Diagnoselabore
  • Krankenhäuser
  • Krebsforschungsinstitute
  • Kliniken
  • Ambulante Chirurgische Zentren
  • Sonstiges

Vertriebskanal

  • Direkte Ausschreibung
  • Einzelhandelsumsätze

Globaler Markt für Prostatakrebsdiagnostik – Regionale Analyse/Einblicke

Der Markt für Prostatakrebsdiagnostik wird analysiert und Einblicke in die Marktgröße und Trends werden nach Produkttyp, Diagnostiktyp, Altersgruppe, Typ, Stadium, Probentyp, Endbenutzer und Vertriebskanal bereitgestellt, wie oben angegeben.

Die im Marktbericht abgedeckten Länder sind die USA, Kanada, Mexiko, Deutschland, Großbritannien, Frankreich, Italien, Spanien, Niederlande, Russland, Schweiz, Türkei, übriges Europa, Japan, China, Australien, Indien, Südkorea, Singapur, Indonesien, Thailand, Malaysia, Philippinen, übriger Asien-Pazifik-Raum, Brasilien, Argentinien, übriges Südamerika, Saudi-Arabien, Südafrika, Vereinigte Arabische Emirate, Israel, Ägypten sowie der Rest des Nahen Ostens und Afrikas.

Aufgrund der höheren Gesundheitsausgaben in der Region und der gut ausgestatteten Gesundheitseinrichtungen zur Durchführung von Diagnosetests auf Prostatakrebs wird Nordamerika voraussichtlich den Markt dominieren.

Aufgrund der steigenden Zahl an Prostatakrebserkrankungen wird für den Asien-Pazifik-Raum im Prognosezeitraum mit der höchsten durchschnittlichen jährlichen Wachstumsrate gerechnet.

Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Trends des Marktes auswirken. Datenpunkte wie Downstream- und Upstream-Wertschöpfungskettenanalysen, technische Trends und Porters Fünf-Kräfte-Analyse sowie Fallstudien sind einige der Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Bereitstellung von Prognoseanalysen der Länderdaten werden auch die Präsenz und Verfügbarkeit globaler Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen inländischer Zölle und Handelsrouten berücksichtigt.   

Wachstum der Gesundheitsinfrastruktur, installierte Basis und Durchdringung mit neuen Technologien

Der Markt für Prostatakrebsdiagnostik bietet Ihnen außerdem eine detaillierte Marktanalyse für jedes Land, das Wachstum der Gesundheitsausgaben für Investitionsgüter, die installierte Basis verschiedener Arten von Produkten für den Markt für Prostatakrebsdiagnostik, die Auswirkungen der Technologie anhand von Lebenslinienkurven und Änderungen der regulatorischen Szenarien im Gesundheitswesen und deren Auswirkungen auf den Markt für Prostatakrebsdiagnostik. Die Daten sind für den historischen Zeitraum 2010–2020 verfügbar.

Wettbewerbsumfeld und globale Marktanteilsanalyse für Prostatakrebsdiagnostik

Die Wettbewerbslandschaft auf dem Markt für Prostatakrebsdiagnostik liefert Details nach Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, globale Präsenz, Produktionsstandorte und -anlagen, Produktionskapazitäten, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktbreite und -umfang, Anwendungsdominanz. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus der Unternehmen in Bezug auf den Markt für Prostatakrebsdiagnostik.

Zu den wichtigsten Akteuren auf dem Markt für Prostatakrebsdiagnostik zählen:

  • F. Hoffmann-La Roche AG (Schweiz)
  • ACON Laboratories, Inc. (USA)
  • HUMASIS (Südkorea)
  • Teco Diagnostics (USA)
  • Hologic Inc. (USA)
  • Accuquik-Testkits (USA)
  • MDxHealthcare (Belgien)
  • Abbott (USA)
  • Siemens Healthcare GmbH (Deutschland)
  • OPKO Health Inc. (USA)
  • Myriad Genetics, Inc. (USA)
  • DiaSorin SpA (Italien)
  • Beckman Coulter, Inc. (eine Tochtergesellschaft von Danaher) (USA)
  • Genomic Health, Inc. (eine Tochtergesellschaft der Exact Sciences Corporation) (USA)
  • bioMérieux SA (Frankreich)
  • Metamark Genetics, Inc. (USA)
  • Prostatype Genomics (Schweiz)
  • Fujirebio (Belgien)
  • Proteomedix (Schweiz)
  • Eurolyser Diagnostica GmbH (Österreich)

SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Sample Image Klicken Sie auf das Bild, um es zu vergrößern
  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Inhaltsverzeichnis

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. product type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET end users coverage GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Epidemiology
  5. COMPARATIVE ANALYSIS WITH PARENT MARKET
  6. REGULATORY FRAMEWORK: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
    1. REGULATORY SCENARIO IN THE U.S.
    2. REGULATORY SCENARIO IN EUROPEAN UNION
    3. REGULATORY SCENARIO IN JAPAN
    4. REGULATORY SCENARIO IN CHINA
  7. market overview
    1. drivers
      1. INCREASING PREVALENCE OF PROSTATE CANCER
      2. INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
      3. INCREASE IN GERIATRIC POPULATION
      4. LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
      5. DISEASE CAUSING PROSTATE CANCER
    2. RESTRAINTS
      1. CONTROVERSY RELATED TO PSA TESTING
      2. HIGH COST OF DIAGNOSTICS PROCEDURE
      3. LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    3. OPPORTUNITIES
      1. RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
      2. REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
      3. GOVERNMENT INITIATIVES TOWARDS CANCER DIAGNOSTICS
      4. RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
    4. Challenges
      1. STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
      2. OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
      3. INACCURATE DIAGNOSIS RESULTS
  8. IMPACT OF COVID-19 ON GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
    5. KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
    6. CONCLUSION
  9. global PROSTATE CANCER DIAGNOSTICS MARKET, BY product type
    1. overview
    2. reagents & consumables
    3. instruments
    4. accessories
  10. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE
    1. overview
    2. preliminary screening tests
      1. Prostate-Specific Antigen (PSA) Test
      2. Digital Rectal Exam (DRE) Test
    3. Confirmatory Tests
      1. PCA3 Test
      2. biopsy
      3. imaging tests
        1. ULTRASOUND
        2. MAGNETIC RESONANCE IMAGING (MRI)
          1. MULTIPARAMETRIC MRI
          2. MRI FUSION-GUIDED PROSTATE BIOPSY
        3. CT SCAN
        4. BONE SCAN
        5. PET/CT SCAN
      4. biomarker
        1. RNA BIOMARKERS
        2. DNA BIOMARKERS
        3. PROTEIN BIOMARKERS
  11. Global prostate cancer diagnostics Market, By type
    1. overview
    2. PROSTATIC ADENOCARCINOMA
    3. small cell carcinoma
    4. Others
  12. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP
    1. overview
    2. geriatrics
    3. adult
    4. Pediatric
  13. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY Stage
    1. overview
    2. LOCALIZED PROSTATE CANCER
    3. RECURRENT/ADVANCED PROSTATE CANCER
    4. CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)
  14. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY sample type
    1. overview
    2. Blood
    3. tissue
    4. urine
    5. others
  15. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY end users
    1. overview
    2. Independent Diagnostic Laboratories
    3. hospitals
    4. Clinics
    5. Ambulatory Surgical Centers
    6. Cancer Research Institutes
    7. others
  16. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY Distribution Channel
    1. overview
    2. direct tender
    3. retail sales
  17. GLOBAL Prostate cancer diagnostics maRKET, BY GEOGRAPHY
    1. OVERVIEW
    2. NORTH AMERICA
      1. u.s.
      2. canada
      3. mexico
    3. europe
      1. GERMANY
      2. FRANCE
      3. u.k.
      4. iTALY
      5. SPAIN
      6. RUSSIA
      7. SWITZERLAND
      8. NETHERLANDS
      9. TURKEY
      10. bELGIUM
      11. REST OF EUROPE
    4. Asia - Pacific
      1. CHINA
      2. JAPAN
      3. India
      4. Australia
      5. SOUTH KOREA
      6. SINGAPORE
      7. THAILAND
      8. MALAYSIA
      9. INDONESIA
      10. Philippines
      11. REST OF ASIA - PACIFIC
    5. south AMERICA
      1. BRAZIL
      2. ARGENTINa
      3. rest of south america
    6. Middle east & africa
      1. SOUTH AFRICA
      2. saudi arabia
      3. uAE
      4. iSRAEL
      5. EGYPT
      6. REST OF MIDDLE EAST & AFRICA
  18. Global Prostate cancer diagnostics market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  19. SWOT
  20. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHot
      2. REVENUE ANALYSIS
      3. company share analysis
      4. product Portfoli0
      5. RECENT DEVELOPMENTs
    2. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. siemens HEALTHCARE gmbh
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. OPko HEALTH INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Beckman Coulter, Inc. (A Subsidiary of Danaher)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. ACCUQUIK TEST KITS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. acon laboratories inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Biomerieux sa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    9. Diasorin s.p.a
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLI0
      4. RECENT DEVELOPMENTS
    10. Eurolyser Diagnostica GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. FUJIREBIO
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI
      3. RECENT DEVELOPMENTS
    12. GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. HOLOGIC, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. HUMASIS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. MDXHEALTHCARE
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. Metamark genetics, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI0
      3. RECENT DEVELOPMENTS
    17. Myraid genetics, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    18. Prostatype Genomics
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. PROTEOMEDIX
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. TECO DIAGNOSTICS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  21. questionnaire
  22. related reports

Tabellenverzeichnis

TABLE 1 CATEGORIZATION UNDER THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA '88) OF 1988

TABLE 2 AGE AND PROBABILITY OF DEVELOPING PROSTATE CANCER

TABLE 3 global PROSTATE CANCER DIAGNOSTICS Market, By product type 2019-2028 (USD Million)

TABLE 4 global PROSTATE CANCER DIAGNOSTICS Market, By product type 2019-2028 (UNits)

TABLE 5 global reagents & consumables in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 6 globaL instruments in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 7 globaL accessories in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 8 global PROSTATE CANCER DIAGNOSTICS Market, By DIAGNOSTICS TYPE, 2019-2028 (USD Million)

TABLE 9 global preliminary screening tests in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 10 global Confirmatory Testsin PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 11 Global prostate cancer diagnostics market, By type, 2019-2028 (USD million)

TABLE 12 Global prostatic Adenocarcinomas in prostate cancer diagnostics market, By Type 2019-2028 (USD Million), By Region

TABLE 13 Global small cell carcinoma in prostate cancer diagnostics market, By type, 2019-2028 (USD million)

TABLE 14 Global Others in prostate cancer diagnostics market, By type, 2019-2028 (USD million)

TABLE 15 global PROSTATE CANCER DIAGNOSTICS Market, By age group 2019-2028 (USD Million)

TABLE 16 global geriatrics in PROSTATE CANCER DIAGNOSTICS Market, By region 2019-2028 (USD Million)

TABLE 17 global severe in PROSTATE CANCER DIAGNOSTICS Market, By region, 2019-2028 (USD Million)

TABLE 18 global severe in PROSTATE CANCER DIAGNOSTICS Market, By region, 2019-2028 (USD Million)

TABLE 19 Global Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 20 Global Localized Prostate Cancer in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 21 Global Recurrent/Advanced Prostate Cancer in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 22 Global Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic) in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 23 Global Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 24 Global Blood in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 25 Global Tissue in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 26 Global Urine in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 27 Global Others in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 28 Global Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 29 Global Independent Diagnostic Laboratories in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 30 Global Hospitals in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 31 Global Clinics in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 32 Global Ambulatory Surgical Centers in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 33 Global Cancer Research Institutes in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 34 Global Others in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 35 Global Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 36 Global Direct Tender in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 37 Global Hospitals in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 38 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 North America PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 40 North America Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 41 North America Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 42 North America Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 43 North America Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 44 North America Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 45 North America Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 46 North America Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 47 North America Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 48 North America Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 49 North America Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 50 North America Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 51 North America Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 52 North America Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 53 North America Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 54 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 55 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 56 U.S. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 57 U.S. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 58 U.S. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 59 U.S. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 60 U.S. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 61 U.S. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 62 U.S. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 63 U.S. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 64 U.S. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 65 U.S. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 66 U.S. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 67 U.S. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 68 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 69 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 70 CANADA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 71 CANADA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 72 CANADA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 73 CANADA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 74 CANADA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 75 CANADA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 76 CANADA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 77 CANADA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 78 CANADA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 79 CANADA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 80 CANADA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 81 CANADA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 82 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 83 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 84 MEXICO Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 85 MEXICO Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 86 MEXICO Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 87 MEXICO Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 88 MEXICO Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 89 MEXICO Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 90 MEXICO Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 91 MEXICO Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 92 MEXICO Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 93 MEXICO Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 94 MEXICO Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 95 MEXICO Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 96 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 97 EUROPE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 98 EUROPE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 99 EUROPE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 100 EUROPE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 101 EUROPE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 102 EUROPE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 103 EUROPE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 104 EUROPE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 105 EUROPE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 106 EUROPE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 107 EUROPE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 108 EUROPE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 109 EUROPE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 110 EUROPE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 111 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 112 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 113 GERMANY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 114 GERMANY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 115 GERMANY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 116 GERMANY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 117 GERMANY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 118 GERMANY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 119 GERMANY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 120 GERMANY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 121 GERMANY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 122 GERMANY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 123 GERMANY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 124 GERMANY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 125 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 126 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 127 FRANCE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 128 FRANCE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 129 FRANCE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 130 FRANCE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 131 FRANCE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 132 FRANCE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 133 FRANCE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 134 FRANCE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 135 FRANCE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 136 FRANCE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 137 FRANCE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 138 FRANCE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 139 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 140 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 141 U.K. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 142 U.K. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 143 U.K. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 144 U.K. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 145 U.K. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 146 U.K. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 147 U.K. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 148 U.K. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 149 U.K. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 150 U.K. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 151 U.K. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 152 U.K. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 153 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 154 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 155 ITALY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 156 ITALY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 157 ITALY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 158 ITALY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 159 ITALY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 160 ITALY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 161 ITALY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 162 ITALY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 163 ITALY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 164 ITALY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 165 ITALY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 166 ITALY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 167 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 168 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 169 SPAIN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 170 SPAIN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 171 SPAIN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 172 SPAIN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 173 SPAIN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 174 SPAIN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 175 SPAIN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 176 SPAIN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 177 SPAIN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 178 SPAIN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 179 SPAIN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 180 SPAIN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 181 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 182 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 183 RUSSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 184 RUSSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 185 RUSSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 186 RUSSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 187 RUSSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 188 RUSSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 189 RUSSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 190 RUSSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 191 RUSSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 192 RUSSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 193 RUSSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 194 RUSSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 195 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 196 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 197 SWITZERLAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 198 SWITZERLAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 199 SWITZERLAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 200 SWITZERLAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 201 SWITZERLAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 202 SWITZERLAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 203 SWITZERLAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 204 SWITZERLAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 205 SWITZERLAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 206 SWITZERLAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 207 SWITZERLAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 208 SWITZERLAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 209 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 210 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 211 NETHERLANDS Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 212 NETHERLANDS Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 213 NETHERLANDS Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 214 NETHERLANDS Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 215 NETHERLANDS Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 216 NETHERLANDS Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 217 NETHERLANDS Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 218 NETHERLANDS Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 219 NETHERLANDS Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 220 NETHERLANDS Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 221 NETHERLANDS Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 222 NETHERLANDS Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 223 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 224 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 225 TURKEY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 226 TURKEY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 227 TURKEY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 228 TURKEY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 229 TURKEY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 230 TURKEY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 231 TURKEY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 232 TURKEY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 233 TURKEY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 234 TURKEY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 235 TURKEY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 236 TURKEY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 237 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 238 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 239 BELGIUM Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 240 BELGIUM Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 241 BELGIUM Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 242 BELGIUM Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 243 BELGIUM Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 244 BELGIUM Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 245 BELGIUM Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 246 BELGIUM Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 247 BELGIUM Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 248 BELGIUM Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 249 BELGIUM Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 250 BELGIUM Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 251 rest of europe Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 252 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 253 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 254 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 255 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 256 ASIA - PACIFIC Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 257 ASIA - PACIFIC Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 258 ASIA - PACIFIC Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 259 ASIA - PACIFIC Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 260 ASIA - PACIFIC Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 261 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 262 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 263 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 264 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 265 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 266 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 267 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 268 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 269 CHINA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 270 CHINA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 271 CHINA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 272 CHINA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 273 CHINA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 274 CHINA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 275 CHINA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 276 CHINA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 277 CHINA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 278 CHINA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 279 CHINA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 280 CHINA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 281 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 282 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 283 JAPAN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 284 JAPAN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 285 JAPAN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 286 JAPAN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 287 JAPAN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 288 JAPAN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 289 JAPAN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 290 JAPAN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 291 JAPAN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 292 JAPAN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 293 JAPAN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 294 JAPAN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 295 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 296 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 297 INDIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 298 INDIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 299 INDIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 300 INDIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 301 INDIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 302 INDIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 303 INDIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 304 INDIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 305 INDIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 306 INDIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 307 INDIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 308 INDIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 309 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 310 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 311 AUSTRALIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 312 AUSTRALIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 313 AUSTRALIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 314 AUSTRALIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 315 AUSTRALIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 316 AUSTRALIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 317 AUSTRALIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 318 AUSTRALIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 319 AUSTRALIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 320 AUSTRALIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 321 AUSTRALIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 322 AUSTRALIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 323 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 324 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 325 SOUTH KOREA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 326 SOUTH KOREA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 327 SOUTH KOREA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 328 SOUTH KOREA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 329 SOUTH KOREA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 330 SOUTH KOREA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 331 SOUTH KOREA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 332 SOUTH KOREA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 333 SOUTH KOREA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 334 SOUTH KOREA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 335 SOUTH KOREA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 336 SOUTH KOREA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 337 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 338 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 339 SINGAPORE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 340 SINGAPORE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 341 SINGAPORE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 342 SINGAPORE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 343 SINGAPORE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 344 SINGAPORE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 345 SINGAPORE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 346 SINGAPORE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 347 SINGAPORE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 348 SINGAPORE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 349 SINGAPORE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 350 SINGAPORE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 351 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 352 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 353 THAILAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 354 THAILAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 355 THAILAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 356 THAILAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 357 THAILAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 358 THAILAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 359 THAILAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 360 THAILAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 361 THAILAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 362 THAILAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 363 THAILAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 364 THAILAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 365 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 366 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 367 MALAYSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 368 MALAYSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 369 MALAYSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 370 MALAYSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 371 MALAYSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 372 MALAYSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 373 MALAYSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 374 MALAYSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 375 MALAYSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 376 MALAYSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 377 MALAYSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 378 MALAYSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 379 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 380 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 381 INDONESIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 382 INDONESIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 383 INDONESIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 384 INDONESIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 385 INDONESIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 386 INDONESIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 387 INDONESIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 388 INDONESIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 389 INDONESIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 390 INDONESIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 391 INDONESIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 392 INDONESIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 393 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 394 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 395 PHILIPPINES Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 396 PHILIPPINES Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 397 PHILIPPINES Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 398 PHILIPPINES Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 399 PHILIPPINES Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 400 PHILIPPINES Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 401 PHILIPPINES Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 402 PHILIPPINES Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 403 PHILIPPINES Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 404 PHILIPPINES Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 405 PHILIPPINES Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 406 PHILIPPINES Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 407 rest of Asia - Pacific Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 408 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 409 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 410 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 411 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 412 SOUTH AMERICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 413 SOUTH AMERICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 414 SOUTH AMERICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 415 SOUTH AMERICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 416 SOUTH AMERICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 417 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 418 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 419 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 420 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 421 SOUTH AMERICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 422 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 423 BRAZIL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 424 BRAZIL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 425 BRAZIL Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 426 BRAZIL Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 427 BRAZIL Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 428 BRAZIL Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 429 BRAZIL Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 430 BRAZIL Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 431 BRAZIL Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 432 BRAZIL Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 433 BRAZIL Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 434 BRAZIL Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 435 BRAZIL Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 436 BRAZIL Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 437 ARGENTINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 438 ARGENTINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 439 ARGENTINA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 440 ARGENTINA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 441 ARGENTINA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 442 ARGENTINA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 443 ARGENTINA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 444 ARGENTINA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 445 ARGENTINA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 446 ARGENTINA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 447 ARGENTINA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 448 ARGENTINA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 449 ARGENTINA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 450 ARGENTINA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 451 rest of south america Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 452 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 453 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 454 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 455 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 456 MIDDLE EAST & AFRICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 457 MIDDLE EAST & AFRICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 458 MIDDLE EAST & AFRICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 459 MIDDLE EAST & AFRICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 460 MIDDLE EAST & AFRICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 461 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 462 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 463 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 464 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 465 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 466 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 467 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 468 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 469 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 470 SOUTH AFRICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 471 SOUTH AFRICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 472 SOUTH AFRICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 473 SOUTH AFRICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 474 SOUTH AFRICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 475 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 476 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 477 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 478 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 479 SOUTH AFRICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 480 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 481 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 482 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 483 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 484 SAUDI ARABIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 485 SAUDI ARABIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 486 SAUDI ARABIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 487 SAUDI ARABIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 488 SAUDI ARABIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 489 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 490 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 491 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 492 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 493 SAUDI ARABIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 494 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 495 UAE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 496 UAE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 497 UAE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 498 UAE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 499 UAE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 500 UAE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 501 UAE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 502 UAE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 503 UAE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 504 UAE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 505 UAE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 506 UAE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 507 UAE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 508 UAE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 509 ISRAEL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 510 ISRAEL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 511 ISRAEL Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 512 ISRAEL Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 513 ISRAEL Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 514 ISRAEL Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 515 ISRAEL Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 516 ISRAEL Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 517 ISRAEL Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 518 ISRAEL Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 519 ISRAEL Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 520 ISRAEL Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 521 ISRAEL Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 522 ISRAEL Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 523 EGYPT Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 524 EGYPT Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 525 EGYPT Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 526 EGYPT Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 527 EGYPT Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 528 EGYPT Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 529 EGYPT Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 530 EGYPT Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 531 EGYPT Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 532 EGYPT Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 533 EGYPT Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 534 EGYPT Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 535 EGYPT Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 536 EGYPT Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 537 rest of MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

Abbildungsverzeichnis

FIGURE 1 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: segmentation

FIGURE 2 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET : data triangulation

FIGURE 3 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 Global prostate cancer diagnostics market: MARKET end users coverage GRID

FIGURE 10 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Global prostate cancer diagnostics market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE and asia-pacific is growing at the fastest pace in THE global prostate cancer diagnostics market IN the forecast period of 2021 to 2028

FIGURE 13 INCREASING PREVALENCE OF PROSTATE CANCER and INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICs are DRIVing THE global Prostate cancer diagnostics market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 REAGENTS & CONSUMABLES segment is expected to account for the largest share of the global prostate cancer diagnostics MARKET in 2021 & 2028

FIGURE 15 asia-PACIFIC is the fastest growing market in global Prostate cancer diagnostics market in the forecast period of 2021 to 2028

FIGURE 16 REGULATORY FRAMEWORK FOR APPROVAL PROCESS IN CHINA

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET

FIGURE 18 ESTIMATED INCIDENCE CASES OF PROSTATE CANCER, ALL AGES

FIGURE 19 GERIATRIC POPULATION IN THE EUROPEAN REGION

FIGURE 20 global PROSTATE CANCER DIAGNOSTICS market: BY product type, 2020

FIGURE 21 global PROSTATE CANCER DIAGNOSTICS market: BY product type, 2020-2028 (USD Million)

FIGURE 22 global PROSTATE CANCER DIAGNOSTICS market: BY product type, CAGR (2021-2028)

FIGURE 23 PROSTATE CANCER DIAGNOSTICS market: BY product type, LIFELINE CURVE

FIGURE 24 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, 2020

FIGURE 25 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE 2020-2028 (USD Million)

FIGURE 26 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, CAGR (2021-2028)

FIGURE 27 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, LIFELINE CURVE

FIGURE 28 Global prostate cancer diagnostics market: By type, 2020

FIGURE 29 Global prostate cancer diagnostics market: By type, 2020-2028 (USD Million)

FIGURE 30 Global prostate cancer diagnostics market: By type, CAGR (2020-2028)

FIGURE 31 Global prostate cancer diagnostics market: By type, LIFELINE CURVE

FIGURE 32 global PROSTATE CANCER DIAGNOSTICS market: BY age group, 2020

FIGURE 33 global PROSTATE CANCER DIAGNOSTICS market: BY age group , 2020-2028 (USD Million)

FIGURE 34 global PROSTATE CANCER DIAGNOSTICS market: BY age group, CAGR (2021-2028)

FIGURE 35 global PROSTATE CANCER DIAGNOSTICS market: BY age group, LIFELINE CURVE

FIGURE 36 global PROSTATE CANCER DIAGNOSTICS market: BY stage, 2020

FIGURE 37 global PROSTATE CANCER DIAGNOSTICS market: BY stage, 2020-2028 (USD Million)

FIGURE 38 global PROSTATE CANCER DIAGNOSTICS market: BY stage, CAGR (2021-2028)

FIGURE 39 global PROSTATE CANCER DIAGNOSTICS market: BY stage, LIFELINE CURVE

FIGURE 40 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, 2020

FIGURE 41 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, 2020-2028 (USD Million)

FIGURE 42 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, CAGR (2021-2028)

FIGURE 43 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, LIFELINE CURVE

FIGURE 44 global PROSTATE CANCER DIAGNOSTICS market: BY end users, 2020

FIGURE 45 global PROSTATE CANCER DIAGNOSTICS market: BY end users, 2020-2028 (USD Million)

FIGURE 46 global PROSTATE CANCER DIAGNOSTICS market: BY end users, CAGR (2021-2028)

FIGURE 47 global PROSTATE CANCER DIAGNOSTICS market: BY end users, LIFELINE CURVE

FIGURE 48 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, 2020

FIGURE 49 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 50 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, CAGR (2021-2028)

FIGURE 51 global PROSTATE CANCER DIAGNOSTICS market: BY distribution, LIFELINE CURVE

FIGURE 52 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: SNAPSHOT (2020)

FIGURE 53 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020)

FIGURE 54 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 55 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 56 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY pRODUCT type (2020-2028)

FIGURE 57 North America Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 58 North America Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 59 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 60 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 61 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 62 EUROPE Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 63 EUROPE Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 64 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 65 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 66 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 67 ASIA - PACIFIC Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 68 ASIA - PACIFIC Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 69 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 70 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 71 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 72 SOUTH AMERICA Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 73 SOUTH AMERICA Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 74 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 75 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 76 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 77 MIDDLE EAST & AFRICA Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 78 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 79 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 80 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 81 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 82 Global Prostate cancer diagnostics market: company share 2020 (%)

FIGURE 83 north america Prostate cancer diagnostics market: company share 2020 (%)

FIGURE 84 europe Prostate cancer diagnostics market: company share 2020 (%)

FIGURE 85 Asia-Pacific Prostate cancer diagnostics market: company share 2020 (%)

Detaillierte Informationen anzeigen Right Arrow

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The prostate cancer diagnostics market size will be worth USD 9.327.01 million by 2031.
The growth rate of the prostate cancer diagnostics market is 10.50% during the forecast period by 2031.
The increasing aging population & rising incidence of prostate cancer are the growth drivers of the prostate cancer diagnostics market.
Product type, diagnostics type, age group, type, stage, sample type, end-user, and distribution channel are the factors on which the prostate cancer diagnostics market research is based.
Major companies in the prostate cancer diagnostics market are F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), HUMASIS (South Korea), Teco Diagnostics (U.S.), Hologic Inc. (U.S.), Accuquik Test Kits (U.S.), MDxHealthcare (Belgium), Abbott (U.S.), Siemens Healthcare GmbH (Germany), OPKO Health Inc. (U.S.), Myriad Genetics, Inc. (U.S.), DiaSorin S.p.A (Italy), Beckman Coulter, Inc. (a subsidiary of Danaher) (U.S.), Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation) (U.S.), bioMérieux SA (France), Metamark Genetics, Inc. (U.S.), Prostatype Genomics (Switzerland), Fujirebio (Belgium), Proteomedix (Switzerland), Eurolyser Diagnostica GmbH (Austria).

Verwandte Seiten durchsuchen

Banner